Research and Development

The Research and Development team at Enterome focuses on the discovery, design, and advancement of small protein and peptide drug candidates that modulate the immune system to fight cancer. This team conducts preclinical and clinical studies, analyzes data to optimize therapeutic efficacy, identifies biomarkers, and collaborates across disciplines to translate innovative research into viable treatments, currently targeting hard-to-treat tumors such as glioblastoma, adrenal malignancies, and colorectal cancer.